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The purpose of this study was to describe our experience with 1.0T MR-SIM 
including characterization, quality assurance (QA) program, and features neces-
sary for treatment planning. Staffing, safety, and patient screening procedures 
were developed. Utilization of an external laser positioning system (ELPS) and 
MR-compatible couchtop were illustrated. Spatial and volumetric analyses were 
conducted between CT-SIM and MR-SIM using a stereotactic QA phantom with 
known landmarks and volumes. Magnetic field inhomogeneity was determined 
using phase difference analysis. System-related, in-plane distortion was evaluated 
and temporal changes were assessed. 3D distortion was characterized for regions 
of interest (ROIs) 5–20 cm away from isocenter. American College of Radiology 
(ACR) recommended tests and impact of ELPS on image quality were analyzed. 
Combined ultrashort echotime Dixon (UTE/Dixon) sequence was evaluated.  
Amplitude-triggered 4D MRI was implemented using a motion phantom (2–10 
phases, ~ 2 cm excursion, 3–5 s periods) and a liver cancer patient. Duty cycle, 
acquisition time, and excursion were evaluated between maximum intensity projec-
tion (MIP) datasets. Less than 2% difference from expected was obtained between 
CT-SIM and MR-SIM volumes, with a mean distance of < 0.2 mm between land-
marks. Magnetic field inhomogeneity was < 2 ppm. 2D distortion was < 2 mm over 
28.6–33.6 mm of isocenter.  Within 5 cm radius of isocenter, mean 3D geometric 
distortion was 0.59 ± 0.32 mm (maximum = 1.65 mm) and increased 10–15 cm 
from isocenter (mean = 1.57 ± 1.06 mm, maximum = 6.26 mm). ELPS interference 
was within the operating frequency of the scanner and was characterized by line 
patterns and a reduction in signal-to-noise ratio (4.6-12.6% for TE = 50–150 ms). 
Image quality checks were within ACR recommendations. UTE/Dixon sequences 
yielded detectability between bone and air. For 4D MRI, faster breathing periods 
had higher duty cycles than slow (50.4% (3 s) and 39.4% (5 s), p < 0.001) and 
~ fourfold acquisition time increase was measured for ten-phase versus two-phase. 
Superior–inferior object extent was underestimated 8% (6 mm) for two-phase 
as compared to ten-phase MIPs, although < 2% difference was obtained for ≥ 4 
phases. 4D MRI for a patient demonstrated acceptable image quality in ~ 7 min. 
MR-SIM was integrated into our workflow and QA procedures were developed. 
Clinical applicability was demonstrated for 4D MRI and UTE imaging to support 
MR-SIM for single modality treatment planning.   
PACS numbers: 87.56.Fc, 87.61.-c, 87.57.cp
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I. INTRODUCTION
Historically, magnetic resonance imaging (MRI) has been integrated into radiotherapy treatment 
planning primarily as an adjunct to computed tomography (CT) to assist in tumor delineation 
for many treatment sites such as brain, liver, head and neck, and prostate. This conventional 
CT-based workflow relies on target and/or organ at risk (OAR) definition on the MRI, and a 
transfer of contours to CT via image registration for subsequent treatment planning. However, 
performing MRI to CT image registration introduces additional systematic uncertainties (typi-
cally ~ 2 mm) that can be detrimental to localization of target and organs at risk.(1,2) Furthermore, 
having two separate simulations burdens the clinical workload and the use of CT-SIM exposes 
the patient to ionizing radiation. Thus, implementing MRI as a stand-alone simulation modality 
(i.e., MR-SIM) for radiation therapy treatment planning is advantageous. To this end, others 
have implemented radiation oncology dedicated MR scanners, including characterization of 
low-field MR, and integration of data into treatment planning for delineation and dose calcula-
tion.(3-5) For example, Mah et al.(4) described their implementation of 0.23T MR-SIM, including 
external lasers used for virtual isocenter and distortion quantification and correction. Kapanen 
et al.(6) described their commissioning process for MRI-only treatment planning at 1.5T, although 
their work was focused specifically on implementation for prostate cancer. Integrated platforms 
between the MRI and linear accelerator, often incorporating patient trolley systems to assist 
with similar setup between imaging and treatment, have also been described.(7-9)  
Recently, dedicated MR-SIM platforms have been introduced, adding features to further 
improve integration into radiation therapy, such as flat tabletops, external laser systems that 
interface with scanner software, and dedicated radiation therapy imaging protocols. Here, 
we describe our initial experience with one of the only radiation therapy-dedicated MR-SIM 
platforms clinically available.(10) While other groups(4,6,11-12) have reported on their implemen-
tation of different components of MRI as a simulator at other field strengths, we add to the 
literature by describing our initial clinical experience with a dedicated 1.0T open dedicated 
MR-SIM platform with a vertical magnetic field design.  Specifically, we describe our person-
nel requirements and safety procedure, initial MR-SIM characterization including distortion 
quantification, establishment of a quality assurance (QA) program, immobilization devices, 
and specialized imaging sequences such as 4D MRI and ultrashort echotime (UTE) and Dixon 
imaging for motion management and bone segmentation, respectively. This work characterizes 
one of the only commercially available radiotherapy-dedicated MR-SIM platforms currently 
available and, coupled with ongoing work generating synthetic CTs(13) for dose calculation and 
the characterization of object-induced distortions, is a first step toward the overarching goal of 
using MR-SIM for single modality simulation at our institution.
 
II. MATERIALS AND METHODS
A.  Safety and personnel requirements for MR-SIM
In the design of the MR-SIM suite, we followed the American College of Radiology (ACR) 
“four zone” concept — to restrict the areas affected by the magnetic field (i.e., Zones III (control 
room) and IV (magnet room)),(14) as shown in Fig. 1(left). Zone I is open to the general public 
and includes any area outside of the MRI environment. Zone II is our MRI preparation area 
used for MR screening, taking patient histories, and patient dressing. Zone II is the region in 
between the uncontrolled Zone I and strictly controlled Zones III and IV. Patients do not move 
from Zone II to Zone III unless under the supervision of Level 2 MR personnel or those who 
have been trained to ensure MR safety guidelines are strictly adhered to for patient, personnel, 
and equipment safety.(14) Our current Level 2 MR personnel consist of MR technologists, diag-
nostic medical physicists, and MR radiologists. By contrast, Level 1 personnel include those 
who have passed minimal safety educational requirements to ensure their safety as they work 
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in Zone III, such as our radiation oncologists, therapy medical physicists, radiation oncology 
nursing staff, radiation therapists, and researchers. According to the ACR, while Level 1 per-
sonnel are allowed unaccompanied access to Zones III and IV, they cannot be responsible for 
non-MR personnel in Zone IV. Our MR-SIM team is led by: 1) a board-certified MR physicist 
who assisted with machine acceptance, quality assurance (QA), parameter optimization for 
clinical protocols, and MR safety training, and 2) a board-certified MR radiologist who provides 
qualitative feedback on image quality and acquisition sequences.  
  
B.  Safety screening and patient workflow 
Efforts are necessary to develop and administer patient and personnel screening documenta-
tion and policies. In our institution, we adhere to existing policies developed by our radiology 
department that are similar to what has been outlined in the literature.(14) Screening includes 
evaluating MR eligibility and the presence of contraindications, such as implanted metal 
objects/implants or nonremovable body piercings, pregnancy, claustrophobia, and inability to 
lie still for > 30 min. The ACR recommends a minimum of two separate MR safety screening 
sessions conducted by two people, one of which is Level II MR personnel.(14) At our institu-
tion, patients are screened on three occasions: 1) initially, before the MR-SIM appointment has 
been scheduled to ensure eligibility, 2) the day of the MR-SIM, often in the radiation oncology 
department, and 3) in Zone II (i.e., before entering Zone III). We typically have our radiation 
oncology nursing staff conduct the initial screening, our radiation therapist conduct the second 
screening the day of the procedure, and the MR technician conduct the final screening before 
the patient is scanned to ensure the most conservative approach to patient safety.  
Due to limitations in the current version of the MR-SIM software (HFO RT Oncology 
Configuration, v3.5.2), we are unable to mark the final isocenter (setup point) using MR images. 
This functionality, including the transfer of isocenter coordinates to the scanner and laser system 
for subsequent patient marking, is expected in a future upgrade. Nevertheless, it is possible to 
use a reference point marking approach, as described in TG-66,(15) where MR-compatible skin 
markers and reference marks could be used. Given the current limitations in the software, our 
current workflow includes performing the CT-SIM and MR-SIM on the same day, with the 
CT-SIM preceding the MR-SIM appointment. We set isocenter and conduct patient marking 
using CT-SIM, and then transfer the isocenter coordinates to the MR-SIM LAP laser software 
(described in Materials & Methods section C.2). The MR-SIM lasers will then move to the 
appropriate sagittal and lateral locations from the marked CT-SIM isocenter, and the immobi-
lized patient can be positioned accordingly. By importing the CT-SIM isocenter in this manner, 
Fig. 1. (Left) Schematic of our MR-SIM suite and corresponding four-zone regions and their uses as recommended 
by the American College of Radiology. (Right) 1.0 T Philips Panorama High Field Open (HFO) magnetic resonance 
system radiation oncology dedicated MR-SIM and its components: (a) external laser positioning system in-room console, 
(b) external laser positioning system (bridge), (c) vertical field magnet, (d) scanner’s integrated laser (i.e., light visor), 
(e) large body coil with solenoid technology, (f) MR-compatible indexed couchtop, and (g) patient support system trolley. 
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patients can then be translated by a known physical offset to the magnet’s isocenter, thereby 
introducing the least amount of distortion in the anatomy of interest. With added functionality, 
future work will involve exploring MR-SIM for patient marking.
An MR-SIM Time Out checklist is also administered before the beginning of scanning to 
ensure patient safety. The Time Out checklist is based on the “Universal Protocol” recom-
mended by the Joint Commission to prevent surgical errors(16) and has been adapted for our 
imaging and radiation therapy process to ensure proper patient identity, treatment site, MRI 
safety screenings, patient positioning, presence of two hearing protection devices (i.e., ear 
plugs and headphones), and absence of skin folds and patient loops (i.e., skin-to-skin contact 
in hands touching) and that the lasers are turned off (see Materials & Methods section H.2.1) 
before scanning procedures are initiated.  
C.  MR simulator and auxiliary components
C.1 MR simulator and software
The 1.0 T Philips Panorama High Field Open (HFO) Magnetic Resonance System (Philips 
Medical Systems, Cleveland, OH) (MR-SIM) was installed in January, 2013 and acceptance 
testing was performed in March, 2013. The system consists of a vertical magnetic field design 
with 160 cm wide aperture and a 45 cm field of view (Fig. 1(right)), which enables lateral table 
translation of up to 28 cm to center the anatomy of interest at the magnet isocenter. Because of the 
vertical field design, dedicated coils with integrated solenoid technology (Fig. 1(e) for the large 
body coil) are used with the receiver elements perpendicular to the body’s long axis. Another 
benefit of the rigid coils is that many MR-compatible immobilization devices can be accom-
modated while maintaining the patient’s external contour for treatment planning purposes.
The MR-SIM has integrated software that includes QA imaging sequences (distortion cor-
rection, laser QA), functionality to swap the laser system (described in detail later), and initial 
radiation therapy Exam Cards (i.e., preprogrammed image acquisition settings) for brain, pelvis, 
head and neck, and gynecological cases.
C.2 Laser systems
The MR-SIM consists of two laser systems:  an integrated laser (Fig. 1(d), also called the “light 
visor”) and MR-compatible external laser positioning system (ELPS) (Fig. 1(b)). The integrated 
light visor laser is a Class II, 635 nm laser at the end of the bore used to select the plane that 
will be positioned in the center of the magnet and to assist with patient positioning. The ELPS 
DORADOnova MR3T (LAP of America Laser Applications, Boynton Beach, FL) consists of 
six Class II sagittal, transverse, and coronal external lasers used for patient positioning and 
translational/rotational alignment. The added external lasers are to enable correlation between 
external skin marks and MR images. The ELPS is similar to the CT-SIM laser system where the 
patient is localized using a virtual isocenter outside of the magnet bore,(15) although the MR-SIM 
software does not currently allow for interactive isocenter marking using patient images. The 
MR console is configured to use the ELPS system for patient positioning, although this com-
munication must be manually enabled on a daily basis. If the patient has undergone a CT-SIM 
with isocenter marking, the isocenter coordinate information can be imported from CT-SIM 
into the ELPS software and loaded. The lasers will then move to the appropriate sagittal and 
lateral locations from the marked isocenter, and the patient can be positioned accordingly. It is 
important to note that, while the patient support system trolley can move vertically, the couch 
does not adjust in the vertical direction once it is inside the bore. Finally, while patients can be 
localized using the ELPS, the table will be laterally translated to move the anatomy of interest 
to the isocenter, which is particularly important for lateral lesions such as breast or extremities. 
During patient scanning, the ELPS must be disabled, as it degrades image quality, as evaluated 
in Materials & Methods section H.2.1.  
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C.3 MR-compatible couchtops
The Indexed Patient Positioning System (IPPS Overlay, CIVCO Medical Solutions, Kalona, 
IA) is a flat couch overlay device with indexing capability with two different sizes: 40 cm width 
for upper body imaging, and 50 cm width for pelvic/lower body imaging. An MR-compatible 
Lok-Bar (CIVCO Medical Solutions, Kalona, IA) consists of three pins to enable consistent 
positioning of immobilization devices between MR-SIM and CT-SIM/radiation therapy. As 
shown in Fig. 1(f), the couchtop sits on the patient support system on top of risers that allow the 
couch to be 18.5 mm above the MR-SIM patient support system and coils, thereby preventing 
the coils from touching the patient or immobilization devices.  The IPPS weight limit is 250 kg 
(550 lbs) and requires two personnel to affix it to the integrated patient support system.
D.  Volumetric analysis
To compare volumes between CT-SIM and MR-SIM, the LUCY 3D Plus QA phantom (Standard 
Imaging, Middleton, WI) (Fig. 2(a)) was employed. The Lucy phantom is a high-precision, 
MR-compatible modular device that is specifically designed to meet the needs required for 
stereotactic QA.(17) For both MR-SIM and CT-SIM acquisitions, the Lucy phantom was affixed 
to its precision leveling base (Fig. 2(b)). Briefly, for MRI scanning, an MRI signal generator 
(i.e., cavity filled with manganese chloride solution) was first fitted into the Lucy phantom to 
produce appropriate levels of MR signal strength, as shown in Fig. 2(a). An MRI volumetric 
insert containing three irregular shapes filled with mineral oil and known volumes was then 
imaged — these volumes were considered the “true volumes” based on the manufacturer-stated 
volume. MR-SIM scans were acquired with both a four element, phased-array head coil and a 
two element, phased-array medium body/spine coil. Two frequently used clinical sequences were 
used: a 3D T1-weighted fast-field echo acquisition sequence (TE/TR/α = 6.9/25 ms/30° and pixel 
bandwidth = 112 Hz/pixel, and a 3D T2 turbo-spin echo sequence (TE/TR/α = 90/3683 ms/90° 
and pixel bandwidth = 150 Hz/pixel). Both sequences used the following parameters: FOV = 
223 × 231 × 40 mm3, acquisition matrix = 332 × 323 mm2, and voxel size ≈ 0.69 × 0.69 × 
1 mm3. For CT-SIM acquisition, a clinical stereotactic radiosurgery brain acquisition protocol 
Fig. 2. Lucy 3D QA phantom used for volumetric, spatial, and registration comparisons between CT-SIM and MR-SIM. 
(a) Clockwise from the top left:  phantom signal generator, Lucy phantom, MR and CT phantom inserts; (b) setup of 
the Lucy phantom using the manufacturer-provided leveling base (red boxes =  placement of CT marker cylinders used 
for spatial fidelity testing; inset: MRI marker cylinders consisting of 2 mm oil beads (two left) and CT marker cylinders 
with 2 mm aluminum beads used for spatial testing (two right)); (c) line profile analysis of the T1-weighted (T1W) and 
T2-weighted (T2W) datasets acquired using the head and body coils and the CT-SIM where the peaks indicate marker 
locations; (d) CT-SIM of the CT marker cylinders; (e) axial T1-weighted MR-SIM scan of the marker cylinders; (f) axial 
CT-SIM scan of the volumetric inserts; (g) axial T1-weighted MR-SIM scan of the volumetric inserts; and (h) image fusion 
of the CT-SIM andT1-weighted MR-SIM datasets. ANT = anterior, POST = posterior, L = left, R = right.
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was used with 1 mm axial slice thickness, 512 × 512 image dimension, 120 kVp, 284 mAs, 
and 0.68 × 0.68 mm pixel spacing. 
All MR-SIM and CT-SIM phantom data were transferred to the Eclipse Treatment Planning 
System (Eclipse TPS, v11.0, Varian Medical Systems, Palo Alto, CA) for subsequent analysis. 
To standardize object contouring, small, medium, and large irregular regions of interest (ROIs) 
were segmented using a set window/level for each modality and automated thresholding in 
Eclipse, as illustrated in Figs. 2(f) and (g), for the CT-SIM and MR-SIM, respectively. Volume 
percent differences were calculated using known manufacturer-stated true volumes. 
E.  Spatial fidelity and image registration
Four marker cylinders, each containing five 2 mm oil beads (MRI) or five 2 mm aluminum 
beads (CT) (Fig. 2(b)), were fit into precision-machined cavities into one hemisphere of the 
Lucy 3D QA Phantom. One end of the cylinders has red etching for orientation purposes, and 
the oil beads and aluminum beads are spaced 5 mm center to center. The marker cylinders are 
oriented in a known, rigid geometry forming a rectangle of 60 mm center to center. Spatial 
fidelity was evaluated by generating line profiles across (right to left) the marker cylinders in 
the axial plane for the CT-SIM, T1-weighted, T2-weighted, and head/body coil datasets, as 
shown in Figs. 2(c) to (e). The peaks of the implanted cylinders were determined by finding the 
local maximum intensity for each marker via a bounding box and search function (OriginLab, 
version 6.1, OriginLab Corporation, Northampton, MA). Peak-picking was visually verified 
and modified to reflect the center of the peak, if necessary. Absolute displacement and percent 
differences from the ground truth were calculated for both CT-SIM and MR-SIM datasets for 
the four locations (anterior, posterior, left, and right, as shown in Fig. 2(c)). MR-SIM to CT-SIM 
image registration was performed in the Eclipse Registration Workspace using automatic, 
intensity-based image registration (rotation/translation) that employs a linear optimization 
method with mutual information calculation.(18) The registration results between the CT and 
MRI marker cylinders were visually inspected for agreement.
F.  Initial magnetic field homogeneity characterization
At time of acceptance, the initial magnetic field homogeneity was characterized using an 
implemented phase difference analysis technique recommended by the ACR.(19) Briefly, a 
31 cm diameter uniform spherical phantom was imaged with the quadrature body coil. Two-
dimensional (2D) gradient echo images were acquired in axial, sagittal, and coronal planes 
using a large FOV covering the phantom with the following parameters: TE1/TE2/TR/α = 
10/12/500 ms/20°, pixel bandwidth = 1420 Hz/pixel, acquisition matrix = 176 × 88 mm2, FOV = 
350 mm2, voxel size ≈ 0.5 × 0.5 × 5 mm3. Phase difference maps were generated between the 
two TE datasets using in-house software to determine the pixel-by-pixel measurement of field 
homogeneity for each axis using the phase images. Images were normalized between 0 and 2π 
and transition zones (i.e., areas where the original phase variation exceeded 2π) were removed 
using a standard phase unwrapping algorithm.(20) A phase difference map was generated by 
subtracting the phase image at TE = 10 ms from that at TE = 12 ms to yield phase difference 
values directly proportional to the magnetic field at each pixel.(21)
G.  Geometric fidelity
Geometric accuracy can be classified into two major components: system-related distortions 
(magnetic field distortions and gradient nonlinearity) and patient/object-induced distortions 
(e.g., chemical shifts and susceptibility). Geometric distortion due to magnetic field inho-
mogeneity and gradient field nonlinearity has been well-documented in the literature,(22-28) 
although not specifically for the 1.0T HFO. Two-dimensional in-plane distortion is evaluated 
for routine daily QA using a vendor-provided geometric planar distortion phantom scanned in 
three planes (axial, sagittal, and coronal) using the integrated quadrature body coil. A vendor-
supplied imaging protocol generates images over ~ 35 cm × 40 cm field of view (FOV) and 2D 
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distortion is quantified using vendor-provided software. The software compares the acquired 
data to an ideal grid of phantom markers, and deviations between the expected and measured 
values based on center of mass analysis. Two-dimensional contours are then interpolated to the 
acquired images based on the calculated deviations, rendering a distortion plot with isocontours 
ranging from 2 to 6 mm for each plane. A rectangular ROI is automatically derived indicating 
the area where > 75% of the distortion is < 2 mm. The MR technician visually verifies that the 
location of the 2 mm isocontour does not extend substantially into the rectangular region, and 
records the dimensions of the rectangular ROI. In this manner, 2D distortion can be assessed 
on a routine basis, before the MR-SIM is used for daily operation, and temporal changes can 
be ascertained.  
Three-dimensional (3D) distortion characterization was performed during MR-SIM accep-
tance using a prototype phantom provided by the vendor. Because of the large phantom size 
(40 cm × 40 cm × 40 cm), the integrated quadrature body coil was used for scanning. The 
phantom consisted of docusate sodium capsules (~ 12 mm length, 6 mm diameter, Fig. 3(a)) 
with 2.5 cm centroid-to-centroid, in-plane spacing and 2.7 cm z-axis centroid-to-centroid spac-
ing, yielding ~ 2500 control points over the phantom volume. The phantom was first scanned 
with CT-SIM (Philips Big Bore, Philips Medical Systems) with 600 mm2 FOV, 2 mm axial 
slice thickness, 120 kVp, 284 mAs, voxel size ≈ 1.19 × 1.19 mm2), as shown in Fig. 3(a)). 
Three-dimensional T1 fast-field echo acquisitions were acquired with the 1.0 T MR-SIM (TE/
TR/α = 3.83/9 ms/10°, pixel bandwidth = 191 Hz/pixel, voxel size ≈ 0.938 × 0.938 × 1 mm3, 
acquired using a FOV of 450 × 450 × 400 mm3), as shown in Fig. 3(b).  
To derive a 3D distortion map, deformable image registration (DIR) was conducted using 
Velocity Advanced Imaging (VelocityAI, v3.0.0, Velocity Medical Solutions, Atlanta, GA). 
We have previously benchmarked VelocityAI DIR using 11 computational models developed 
via finite element methods (FEM) from patient lung CT scans with simulated motion ranging 
from 1.8 cm to 3 cm.(29) FEM-generated displacement vector fields (DVFs) served as the gold 
standard and mean errors were 1.0 ~ 3.0 mm for the computational phantoms, with regions 
of large displacements yielding larger registration errors. Extrapolating these results to much 
smaller distortion magnitudes expected in MR-SIM, < 1 mm errors can be expected. Because 
Fig. 3. (a) Axial CT scan of the phantom demonstrating the capsule array, (b) 1.0T axial scan at similar slice location, 
(c) region of interests from isocenter used for distortion analysis between MR-SIM and CT-SIM, and (d) distortion vector 
analysis between MR-SIM and CT-SIM at the different radii.
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the phantom was in slightly different positions between MR-SIM and CT-SIM, manual matching 
and automated rigid registration (1 pass) were performed. Then, deformable (1 pass) registration 
was implemented between the MR-SIM and CT-SIM data. With a perfect DIR, the deformed 
image should be exactly the same as the fixed image. Visual verification of the congruence of 
the MR-SIM and CT-SIM images was assessed through an overlay and checked via the split 
view, blending view, and spyglass tools available in VelocityAI, which is consistent with our 
clinical practices.(30) Image congruence was found to improve when the MR-SIM data was 
used as the primary dataset. When CT-SIM was used as the primary dataset, the larger FOV 
caused erroneous expansion of the MR-SIM volume at the image boundaries. In addition, 
the MR-SIM data showed some signal loss at the boundary (Fig. 3(b)), which may also have 
affected the DIR performance.  
DVFs between the MR-SIM and CT-SIM data were used to describe the vector distortion 
magnitude. Distortion histograms (i.e., percent volume versus vector distortion magnitude) 
for several ROIs around isocenter were derived (5 cm radius sphere, 5–10 cm radius annulus, 
10–15 cm radius annulus, and 15–20 cm radius annulus, as shown in Fig. 3(c) and (d)).  
H.  Daily quality assurance procedures
Daily quality assurance procedures are all conducted by the MR technician on days that the 
MR-SIM is in clinical or research use.  
H.1 Image quality assessment
For ongoing daily quality assurance, we use a manufacturer-provided Plexiglas phantom 
(200 mm diameter, 110 mm length) containing fluid with known relaxation time accuracy of 
± 5%. Vendor-supplied PIQT software is used that includes modules for all of the weekly ACR 
performance tests, including automated measures of table positioning accuracy, central (i.e., 
resonant) frequency, and transmitted gain. Image quality metrics are assessed using National 
Electrical Manufacturers Association (NEMA) standards that were developed to enable com-
parisons across other MR systems.(31,32) Tests included spatial resolution, low-contrast detect-
ability, flood-field uniformity, and artifact detection (e.g., ghosting or lines). The PIQT also 
includes annual ACR QA recommendations, such as slice thickness accuracy (full width half 
maximum (FWHM) of a 1 mm thick standard crossed-ramp phantom insert (~ 11° angle)) and 
integral uniformity. Results are monitored daily by the MR technician (see Appendix A) and 
on a monthly basis by the physicist performing monthly QA. 
H.2 Laser quality assurance
H.2.1 Isocenter offset and alignment
An offset between the external bridge lasers and the magnet isocenter is determined at time 
of commissioning and verified before daily use, in a manner analogous to CT-SIM.  The LAP 
Aquarius MR phantom (Laser Alignment (LA phantom); LAP of America Laser Applications) 
and three-point leveling platform for routine laser QA are used for daily laser QA. The phantom 
has copper sulfate signal generators and a 2 mm thick, 15 cm long by 15 cm wide oil-filled 
internal crosshair that is imaged in each plane. Etched scribes on the external phantom sur-
face coincide with the internal crosshair. The leveling platform affixes to the IPPS table and 
phantom grooves are aligned to the sagittal, transverse, and coronal external LAP lasers for 
translational and rotational alignment. The body coil is connected over the top of the phantom, 
and the phantom is automatically translated to the magnet isocenter inside the bore using the 
established offset. Twenty-four images (8 in each orientation) are acquired using 2.0 mm slice 
thickness, 0 mm gap, and 200 mm field of view based on a vendor-supplied protocol. The offsets 
are then characterized by assessing the deviations of the internal crosshair from the origin in 
the anterior–posterior, right–left, and foot–head directions. A similar procedure is conducted 
to test the known longitudinal offset of the light visor laser (i.e., scanner’s integrated laser). 
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Offsets of the internal crosshair from the implanted markers are recorded in all directions and 
are expected to be < 2 mm.
H.2.2 Laser impact on image quality
Because the ELPS is positioned inside the MR room, when powered on, the system produces 
radiofrequency interference that generates MR image artifacts. To characterize the impact on 
image quality, two separate tests were conducted: a spurious noise test and the PIQT test with 
and without the ELPS powered on. For the spurious noise test, a service protocol was run that 
isolates and detects other frequencies outside of the scanner. Images were acquired using the 
integrated quadrature body coil. For the PIQT test, image-quality parameters were automati-
cally evaluated using built-in clinical software, including flood field uniformity, SNR, spatial 
linearity, slice profile, and spatial resolution. It should be noted that evaluating SNR may not 
be appropriate for images containing known artifacts;(33) however, it is instructive to verify that 
the established QA procedures will identify and prevent leaving the ELPS powered on during 
patient scanning. In addition, we have established a workflow in our Time Out procedure to 
ensure the ELPS has been powered off prior to patient scanning.  
I.  Monthly quality assurance procedures
I.1 Image quality
Our monthly QA procedures include scanning of a large ACR accreditation phantom to determine 
the minimum levels of performance for well-functioning MRI systems.(34) The phantom contains 
seven image quality modules including: geometric accuracy, high-contrast spatial resolution, 
slice thickness and position accuracy, slice position accuracy, image intensity uniformity, percent 
signal ghosting, and low-contrast object detectability. Results are compared with those acquired 
at time of acceptance testing. We also monitor the central frequency over time.  
I.2 Laser motion and alignment
We follow the recommendations provided by AAPM TG-66 for laser motion and alignment 
monthly QA.(15) The ELPS laser movement should be accurate, linear, and reproducible. The 
LA phantom is first set up and leveled. The phantom has machined grooves that are aligned to 
the ELPS transverse, sagittal, and coronal lasers. To verify that the light visor laser and ELPS 
lasers are parallel and orthogonal to the scan plane, the couchtop is moved longitudinally and 
laterally while the lasers are observed to ensure deviations from the phantom grooves are less 
than ± 2 mm.
To verify the ELPS individual side laser movement, a calibrated ruler is taped to the side 
of the LA phantom. The vertical (Z) position of the side laser on the ruler is recorded. The 
laser is then moved by 200 mm using the in-room control monitor. The position is recorded 
and compared to the expected with a tolerance of 1 mm. The lasers are then sent back to the 
zero position, and the test is repeated for the other side laser. For the sagittal ELPS laser, the 
calibrated ruler is placed on the couchtop perpendicular to the sagittal laser. The sagittal laser 
is moved to +100 mm and -100 mm, and the position of the laser on the ruler is recorded. The 
measured values should be within ± 1 mm of expected values.
J.  Initial patient experience
J.1 Immobilization devices
One of the first tasks for patient scanning included identifying immobilization devices that 
are considered “MR Compatible” according to guidelines set forth by the Food and Drug 
Administration.(35) Our MR-SIM patient experience has primarily included prostate, spine, 
and brain cases. Table 1 demonstrates the coils, immobilization devices, and typical MR-SIM 
sequences acquired. For lumbar spine, the exam time was quite long for 3D scanning and patient 
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motion could sometimes compromise image quality. Thus, we have moved forward with 2D 
protocols for this treatment site to decrease scan time. In addition, we enable sensitivity encod-
ing (SENSE factor of typically 1.3 ~ 2.0), whenever possible, to shorten exam times and reduce 
motion artifacts. Typical exam times are 4–7 min per scan type, although they largely depend 
on the field of view selected. For thoracic spine, we are still refining our imaging techniques 
to acquire high-quality images in the presence of respiratory motion.
All images obtained with the first ten patients scanned with the MR-SIM were reviewed by 
a board-certified radiologist (M.P.) for qualitative image assessment. Feedback was provided 
from the radiologist and sequences were iterated and added as recommended.
J.2 Ultrashort echotime (UTE) and Dixon techniques
Historically, it has been difficult to discriminate between cortical bone and air in MRI images 
due to the extremely short T2 and T2* relaxation times and fast-decaying signals. One solu-
tion includes employing ultrashort echotime (UTE) sequences to assist in cortical bone 
segmentation.(36-38) Using UTE sequences to generate synthetic CTs for treatment planning 
purposes(39,40) or for combined PET/MRI units(41,42) has shown great promise. For tissue clas-
sification, such as distinguishing lipids (i.e., fat) from water, Dixon imaging has also proven 
useful.(39,41,43-45) We have implemented a combined ultrashort echotime (UTE) and Dixon 
(i.e. UTE/Dixon) image sequence on our 1.0T MR-SIM under an IRB-approved prospective 
imaging protocol. The novel two-point Dixon has been shown to improve fat suppression, 
spatial resolution, and image quality in the abdomen compared to standard techniques.(45,46) 
Advantages of combining Dixon and UTE into one image sequence include shortened exam 
time and reduced image registration uncertainties between datasets. The UTE/Dixon sequence 
includes a single triple-echo scan (one free-induction decay and two echoes for Dixon) acquired 
using a 3D center-out radial acquisition mode to enable the shortest TE time possible.  
Table 1. Site-specific coils, immobilization, and imaging sequences optimized for MR-SIM implementation.
 Patient Case Imaging Coil Immobilization Devices Typical Sequences Acquired
Pelvis  • Body coil: • Square sponge under head Whole pelvis
• Prostate   Medium-Extra Large • Angled sponge under • 3D T1-weighted Fast Field Echo
• Gynecological • Integrated quadrature    knees/legs • 3D T2-weighted Turbo Spin Echo 
   coil • Banded feet Cone-down (higher resolution)
  • Hands holding ring • T2-weighted Turbo Spin Echo 
Brain • Head coil • Blue CIVCO Type-S  • 3D T1-weighted 
    Overlay board • 3D T2-weighted Turbo Spin Echo
  • CIVCO 5-point mask • Axial T2-weighted Axial FLAIR
  • Headrest “B”  
    (clear /Silverman)
  • Angled sponge under  
    knees/legs
  • Banded feet
  • Hands holding ring 
Cervical Spine • Head coil • Blue BodyFix bag • 3D T1-weighted
 • Body coil:    (not pump) • 3D T2-weighted Turbo Spin Echo 
   Medium-Extra Large • Half circle leg sponge • VISTA CLEAR
 • Integrated quadrature  • Arms at sides • Balanced Fast Field Echo for 
   coil • Feet neutral   head and neck region
Lumbar Spine • Body coil:  • Blue BodyFix bag • 2D T1-weighted 
   Medium-Extra Large   (not pump) • 2D T2-weighted Turbo Spin Echo
 • Integrated quadrature  • Half circle leg sponge 
   coil • Arms at sides
  • Feet neutral
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For initial implementation, 3D volumetric UTE/Dixon images of a porcine shank were acquired 
with a four element phased-array head coil with the following parameters: TR = 8.14 ms, TE = 
0.144 (UTE), 2.44, and 4.74 ms, flip angle = 25°, and isotropic voxel size ≈ 1.6 × 1.6 × 1.6 mm3, 
and FOV = 230 × 230 × 230 mm3. The images are used to calculate water and fat components, 
with an overall scan time of ~ 5 min for the UTE/Dixon sequence. For comparison purposes, 
T1-weighted turbo-field echo (TR/TE = 7.46/3.69 ms, voxel size ≈ 0.94 × 0.94 × 2.2 mm3) and 
T2-weighted (TR/TE = 3549/80 ms, flip angle = 90°, voxel size ≈ 0.68 × 0.68 × 3 mm3) were 
acquired. Using a similar experimental setup, a CT scan was also conducted using slice thickness 
of 2 mm and in-plane pixel size of 0.68 mm × 0.68 mm3 (512 × 512 matrix). All images were 
interpolated to match the UTE/Dixon image dimensions for comparison purposes. To further 
reduce the signal from longer T2 components, a “bone enhanced” image was generated using 
the Image Algebra postprocessing package available on our scanner. This image was generated 
by scaling the UTE image by a factor of 1.3 and subtracting the in-phase image generated by 
Dixon to further highlight the bone region in the porcine shank. The scaling factor magnitude 
was determined ad hoc based on the optimal suppression of brain tissue while enhancing the 
bone. The bone-enhanced image exhibited a high intensity “halo” of signal around the shank 
that was removed via image postprocessing (i.e., applying an image mask derived from the 
outer surface of the T1 dataset and setting the background to white to provide optimal contrast).
UTE/Dixon scans were conducted for a radiosurgery patient status postresection of a 
left frontal solitary metastasis. The four element phased-array head coil and immobilization 
devices listed in Table 1 were used. Three-dimensional volumetric UTE/Dixon images were 
acquired using the same parameters as the porcine experiment. For comparison purposes, 
a post- Gadolinium enhanced T1-weighted turbo-field echo (TR/TE = 21/6.9 ms, voxel size 
≈ 0.97 × 0.97 × 2.0 mm3 with a FOV = 190 mm (right–left), 233 mm (ant–post), and 164 mm 
(foot–head) was also acquired. A CT scan was also conducted using slice thickness of 2 mm and 
in-plane pixel size of 0.68 mm × 0.68 mm2 (512 × 512 reconstruction matrix), and all images 
were resampled to match the UTE/Dixon image dimensions. A bone-enhanced image was also 
generated for the patient case in a manner similar to the porcine shank.
J.3 Four-dimensional MRI (4D MRI)
J.3.1 4D MRI Algorithm
Efforts are currently underway to evaluate a respiratory-triggered, single-shot T2-weighted TSE 
4D MRI acquisition technique under a prospective IRB-approved protocol. The algorithm is a 
multislice 2D dynamic MRI acquisition that was first introduced by Hu et al.(47) Image acquisition 
of different respiratory states for each MR slice is performed using amplitude-based triggered 
acquisition 4D MRI (described in detail in Reference 35). To ensure better image contrast (e.g., 
by allowing for longer TR times), data sampling is separated into multiple respiratory cycles 
to allow the magnetization to completely relax. During the 4D MRI acquisition, an external 
waveform is derived from a clinically available air-filled cushion and pressure sensor track-
ing device. The waveform is initially tagged at the start of the magnet’s preparation state, and 
once the preparation state has concluded, a calibration period over the first 2 breathing cycles 
is analyzed to determine the trigger levels for the different respiratory phases with respect to 
the maximum and minimum respiratory signal levels obtained. Hu’s approach has been further 
refined to improve clinical efficiency by integrating proprietary measures to reduce acquisition 
time and stabilize triggering due to breathing anomalies.  
 
J.3.2 4D MRI phantom experiment and initial patient result
Phantom experiments were carried out using a programmable respiratory motion platform 
(ExacTrac Gating Phantom, Version 1.0, BrainLAB AG, Feldkirchen, Germany) with string 
attached that pulled a cube-shaped signal generator (and placed on a Lego trolley (LEGO 
Systems A/S, Billund, Denmark) located inside the magnet room (experimental setup shown 
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in Fig. 4). The platform translated the signal generator in the superior–inferior (S-I) direction. 
A chest wall component moving simultaneously in the anterior–posterior direction was used to 
generate a respiratory waveform via a clinically available air-filled cushion and pressure sensor 
tracking device (Fig. 4, left). For a stationary reference, a bottle of signal generator (1000 ml 
bottle of demineralized water/copper sulfate) was scanned in the same FOV. Programmed 
superior–inferior object excursion was ~ 3 cm using a sinusoidal waveform with both 3 and 5 s 
breathing cycles. It should be noted that the actual object excursion was reduced to ~ 1.5–2 cm 
due to the addition of the string and trolley system, which is similar to what has been reported 
in the literature.(48) Two to ten phase T2-weighted TSE 4D MRI images were acquired with TE/
TR/α = 50.25/2000 ms/90°, pixel bandwidth = 259 Hz/pixel, voxel size ≈ 0.98 × 0.98 × 5 mm, 
and FOV = 250 × 201 × 125 mm3. All MRI datasets were exported from the scanner in DICOM 
format. Maximum intensity projections (MIP) were derived using MATLAB (MathWorks, 
Natick, MA) by calculating the maximum intensity values of all voxels throughout all 4D MRI 
phases. Duty cycle (nominal programmed acquisition time divided by overall scan time) and 
excursion were evaluated between phase acquisitions.  
A liver cancer patient consented to a prospective IRB-approved protocol to optimize acquisi-
tion parameters for abdominal 4D MRI (6 phases, TE/TR/α = 75/6100 ms/90°, voxel ≈ 1 × 1 × 
7 mm3). Duty cycle, scan time, and image quality were evaluated between phase acquisitions. For 
image quality comparison purposes, coronal cine-MRI (~ 1 frame/s, ~ 50 s) was also acquired. 
MIP renderings were generated in a manner similar to the phantom experiment. 
 
Fig. 4. (Top) Experimental setup for 4D MRI phantom study, including the motion platform and components located in the 
control room that translate the MR-compatible trolley located in the MR-SIM bore. (Bottom) Coronal view for a ten-phase, 
amplitude-based triggered 4D MRI for a signal generator phantom translating ~ 2 cm in the superior–inferior direction 
(square object, sinusoidal breathing pattern, 3 s period). The percentages describe the breathing phases, with 0% represent-
ing end-inhale and 50% representing end-exhale. The round static signal generator is also shown in the field of view.
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III. RESULTS 
A.  Volumetric analysis
CT-SIM volumes were < 2% different from ground truth (maximum difference = -1.8% (0.03 cc) 
for the smallest insert). T1-and T2-weighted images acquired using the head coil, where the 
signal to noise ratio was appropriate for the size of the object being imaged, were within -1.3% 
and 2.1% of ground truth, respectively, for the larger inserts. Delineations of the small inserts 
were slightly larger than expected (1.2–2.4%, 0.02–0.04 cc). In the medium body/spine coil, 
volumes were consistently smaller than ground truth (-1.7% to -2.7%) for the medium and large 
inserts. However, for the small insert, volumes were equal or slightly larger for the T2- and 
T1-weighted images, respectively. Overall, clinically acceptable results were obtained for both 
CT-SIM and MR-SIM (< 2% difference from manufacturer-stated true volumes). The equivalent 
diameters were < 1 mm different for all CT-SIM and MR-SIM volumes. 
B.  Spatial fidelity and image registration
Figure 2(c) demonstrates the intensity profiles across the CT-SIM and MR-SIM cylindrical 
markers for the different acquisitions and coils. For CT-SIM, the mean distance between  markers 
was 59.83 ± 0.02 mm (< 0.3% difference from expected, 60 mm). For the T1-weighted and 
T2-weighted datasets, the mean distance between markers was 60.05 ± 0.19 mm and 59.99 ± 
0.16, respectively, across both coils (< 0.4% different from expected). When the head coil 
and medium body coil were considered separately, the mean distances were 60.07 ± 0.19 and 
59.97 ± 0.17 mm, respectively. The image fusion shown in Fig. 2(h)(right) demonstrates the 
spatial concordance between the MR-SIM and CT-SIM images after rigid registration.
C.  Initial magnetic field homogeneity characterization
Figure 5 demonstrates the magnetic field inhomogeneity maps of the MR-SIM. The volume 
root mean square was calculated to be 0.9 ppm over 31 cm diameter spherical volume, which 
was within ACR specifications. Due to the vertical magnet design, the coronal datasets show the 
most symmetrical distribution (i.e., left–right, anterior–posterior) because of the equidistance 
from the magnetic field.  
Fig. 5. Change in magnetic field inhomogeneity map characterized at time of acceptance. The volume root mean square 
was calculated to be 0.9 ppm over a 31 cm diameter spherical phantom volume, with an image reconstruction diameter 
of 35 cm.
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D.  Geometric distortion
Two-dimensional distortion characterization was tracked temporally over the first eight months 
of operation via a 2D distortion phantom and assessment of rectangular ROIs to indicate the 
region where > 75% of the distortion was < 2 mm. In the sagittal plane, the ROI dimensions 
were 330.7 ± 13.7 mm (foot–head) and 292.3 ± 6.2 mm (ant–post). In the transverse plane, the 
ROI dimensions were 323.7 ± 10.8 mm (left–right) and 288.8 ± 8.6 mm (ant–post). Finally, in 
the coronal plane, the ROI dimensions were 286.1 ± 16.1 mm (foot–head) and 335.6 ± 10.4 mm 
(left–right). Figure 6 demonstrates the results of the 3D distortion characterization obtained 
via DIR between CT-SIM and MR-SIM images. Distortions at the edges of the FOV can be 
observed in the top row of Fig. 6. Once DIR was applied, the agreement in the marker alignment 
improved substantially. Figure 3(d) summarizes the distortion analysis via the DVFs for varied 
radii from isocenter. Within a 5 cm radius of isocenter, the mean distortion was 0.59 ± 0.32 mm 
(maximum = 1.65 mm).  For 5–10 cm from isocenter, the mean distortion was 0.88 ± 0.51 mm 
(maximum = 3.05 mm). However, farther from isocenter (10–15 cm), distortions were larger 
(mean = 1.57 ± 1.06 mm, maximum = 6.26 mm) and for 15–20 cm from isocenter, distortions 
were 2.37 ± 1.41 mm (maximum = 7.33 mm). Within a 10 cm radius of isocenter, only 3.8% 
of the voxels yielded distortions ranging from 2–3 mm. However, at greater distances from the 
isocenter, 24.3% of the voxels within the 15–20 cm annulus distorted > 3 mm.
Fig. 6. (Top row) Blended overlay of the original CT-SIM (green) and MR-SIM data (orange) prior to deformable image 
registration. Mismatches in marker location can be observed between datasets, particularly near the edges of the field of 
view. (Middle row) Overlay of CT-SIM and MR-SIM data after deformable image registration, showing the resolution 
of image distortions. (Bottom row) Vector distortion magnitude between the CT-SIM and MR-SIM datasets demonstrate 
the distortions occurring near the edges of the field of view. For reference, centroid-to-centroid marker spacing is 2.5 cm 
in-plane and 2.7 cm along the z-axis, and the registration field of view was ~ 40 × 34 × 40 cm3 in the right–left, anterior–
posterior, and superior–inferior, respectively.
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E.  Laser quality assurance
E.1 Isocenter offset and alignment
Periodic laser motion and alignment tests were all within AAPM TG-66 recommendations 
(ELPS < 2 mm deviation across scan plane, absolute laser movement <1 mm from expected) 
over the timeframe tested.  
E.2 Laser impact on image quality
Clear patterns of interference were manifested when the ELPS was turned on during the spuri-
ous noise test. The discrete noise frequencies are within the operating frequency band of the 
MR scanner (not shown). The induced noise exhibited as line patterns rather than as a general 
increase in the background noise. When the PIQT image quality tests were run with the lasers on, 
the signal-to-noise ratio test failed (reduction of 4.6%–12.6% for TE values of 50–150 ms). 
F.  Quality assurance results
A slight reduction in central frequency was measured over time, with the largest day-to-day 
variation of 42 Hz, which was within the ACR recommendations of < 1.5 ppm daily change(19) 
(~ 64 Hz based on our initial acceptance levels). At ~ 120 days postacceptance, a large reduc-
tion (276 Hz from previous measurement) in central frequency was observed. At day 106, the 
MR-SIM unit underwent service, and afterward, the new central frequency (42,587,276 Hz) 
was still within manufacturer specifications (42,584,000–42,591,000 Hz). According to the 
ACR recommendations, a service-related change in center frequency can be accepted provided 
it can be explained, and the center frequency action criteria of < 1.5 ppm can be applied to 
this new baseline.(19) Transmitter gain was stable (0.63 ± 0.01 dB, range: 0.62–0.64 dB) and 
slice thickness accuracy was also consistent (FWHM = 4.94 ± 0.03 mm, nominal slice width = 
5 mm). Little deviation was observed for low contrast detectability, as measured via the SNR 
measurement for the head coil.
G.  Initial patient experience
G.1 Immobilization devices
MR compatible devices in primary use for our scanner include indexing bars, sponges, Alpha 
cradles (Smithers Medical Products Inc., North Canton, OH), Aquaplast masks (Aquaplast Inc., 
Avondale, PA), plastic headrests, rubber bands for banding feet, and BlueBAG BodyFIX Vacuum 
Cushions (Elekta, Stockholm, Sweden;vacuum pump not compatible) as listed in Table 1.  
G.2 UTE/Dixon results
Figure 7 summarizes the CT and MR results for the porcine shank. The fat and water images 
were generated by the Dixon sequences, and the bone-enhanced dataset was generated via 
postprocessing. Note the enhancement of the cortical bone in the UTE image and derived bone-
enhanced image. Figure 8 demonstrates the UTE/Dixon results for the radiosurgery brain case. 
Note that the bone signal is very bright on the CT scan, and there is little to no signal on the 
corresponding T1-Gd, water, or fat Dixon images. On the UTE and in-phase images, however, 
bone signal can be observed. Further image manipulation to highlight the bony features on UTE 
revealed strong bone enhancement. It can be noted that some signal in the left lateral ventricle 
was also highlighted as bone. The high-intensity “halo” signal removed via postprocessing was 
likely caused by the radial acquisition technique. Ideally, the radial spokes (i.e., k-space lines) 
should start from the center of k-space and end on the surface of a sphere, but due to gradient 
delay, an offset exists between the start of the spokes and the center of k-space. This “halo 
effect” can be mitigated by optimizing the selection of the gradient delay (or the trajectory delay 
indicated on our scanner), which is currently under evaluation at our institution. Nevertheless, 
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the clear bone enhancement with UTE compared to other MR sequences is promising for future 
image segmentation work.
G.3 Four-dimensional MRI (4D MRI)
Figure 4 (bottom) summarizes a phantom 4D MRI experiment separated into 10 breathing 
phases. Note the excursion of the square signal generator with respect to the stationary circular 
bottle of signal generator, with a return to near the original location at 90% phase. Faster breath-
ing periods had higher duty cycles than slow (50.4% for 3 s and 39.4% for 5 s, p < 0.001). As 
expected, ~ fourfold acquisition time increase was measured for ten-phase versus two-phase. 
MIP renderings revealed that S-I object extent was underestimated a maximum of 8% (6 mm) 
for two-phase 4D MRI as compared to ten-phase. Acquiring 4 to 10 phases yielded nearly 
equivalent object excursion and volume (< 2% from 10-phase).  
Fig. 8. Axial CT-SIM and 1.0T MR-SIM images for a postsurgical stereotactic radiosurgery patient with a left frontal 
metastasis, including T1 post-Gd, ultrashort echotime (UTE), water and fat images generated via Dixon acquisitions, and 
a bone-enhanced image derived from the in-phase and UTE datasets.
Fig. 7. Axial CT-SIM and 1.0T MR-SIM images for a porcine shank, including ultrashort echotime (UTE), water and fat 
images generated via Dixon acquistions, and a bone-enhanced image derived from the in-phase and UTE datasets.
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Figure 9 shows results for 6-phase liver cancer 4D MRI, showing good image quality and 
no sorting artifacts. The regions of interest were derived on the 4D MRI MIP and overlaid to 
illustrate liver excursion. The nominal scan time was ~ 220 s, while the total acquisition time 
was 440 s, not including the training phase, yielding a duty cycle of ~ 50%. The overall exam 
time was within clinically acceptable limits.
 
IV. DISCUSSION
This work sought to describe the initial clinical experience with a dedicated 1.0T MR-SIM, 
including description of clinical workflow, MR-SIM characterization, establishment of qual-
ity assurance procedures, and initial patient results. Templates for daily QA procedures that 
we have developed at our institution were provided to assist others embarking on MR-SIM 
integration in radiation oncology. Laser QA was conducted as outlined by TG-66 for CT-SIM 
QA, and results were within the specifications (< 2 mm for daily QA, < 2 mm deviation with 
respect to laser scribes with couch motion, and individual laser motions < 1 mm). These results 
are consistent to what was obtained by Mah et al.(4) in their assessment of wall-mounted lasers 
used in routine QA of a 0.23T MR-SIM. While the lasers were shown to be stable, a need exists 
to interface the ELPS directly with the MR-SIM console to enable marking isocenter on the 
MR-SIM images, which will help facilitate MR-only simulation.  
All conducted image quality tests fell and were maintained within accepted criteria. Tracking 
central frequency was sensitive to a change due to machine service, and a slight reduction of 
central frequency over time was observed, as can be expected due to drifting postinstallation. 
The AAPM has suggested that one to two months postacceptance, the central frequency change 
is commonly < 0.25 ppm/day,(49) which will guide our new daily QA procedures.    
To guide our clinicians on the expected accuracy due to image distortion at distances away 
from isocenter, 2D and 3D distortion analysis was conducted. Figure 6 showed that the largest 
displacements between the MR-SIM and CT-SIM occurred near the periphery, most notably 
in the anterior and posterior region for the axial view. This result was also observed in the 
2D distortion analysis, where the 2 mm bounding box dimension of the anterior–posterior 
orientation was consistently smaller than the other dimensions. Because of the vertical field 
design, dedicated coils with integrated solenoid technology (Fig. 1(e) for the large body coil) 
are used with the receiver elements perpendicular to the body’s long axis, thus reducing the 
anterior–posterior FOV. Our analysis revealed that distortions were negligible near scanner 
Fig. 9. (Top) Coronal view for six-phase 4D MRI for a liver cancer patient acquired in ~ 7.4 min. Contours derived from 
CINE-MIP. (Bottom) 4D MRI waveform with respiratory tagging shown.
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isocenter; however, they increased with increased distance from magnet isocenter (> 2 mm in 
a 15–20 cm radius from isocenter). This suggests that efforts to correct for these distortions for 
large field of view acquisitions will be necessary to support MR-SIM only treatment planning. 
It is important to note that the MR-SIM scan of the 3D phantom (Fig. 3b) revealed a circular 
shutter, or mask, was present in the dataset, which could contribute to some DIR uncertainty, 
as we have shown that DIR has some inconsistencies at image boundaries.(29)    
Wang et al.(22) developed a 31 × 31 × 31 cm3 phantom and an algorithm that includes 
> 10,000 control points to evaluate 3D and correct for 3D distortion. The authors were able to 
reduce distortion-induced errors from ~ 10 mm to less than 0.6 mm when their 3D correction 
was applied. In their follow-up paper, 3D distortion of several MR scanners was characterized, 
revealing a strong dependence on distance to isocenter and manufacturer, with two scanners 
demonstrating increases in absolute maximum distortion of 2–3 mm for every 5 mm away from 
isocenter along the z-axis.(50) The 3D distortion phantom described in this work had coarser 
marker spacing (~ 2,500 control points) that are oriented cross-sectionally in the axial plane 
and not in both planes simultaneously, which may limit some of the ability to conduct a full 3D 
analysis. Baldwin et al.(51) used ~ 10,000 control points derived from a CT scan for their work, 
and Doran and colleagues(27) used ~ 16,000 control points for their distortion characterization 
of a 1.5T scanner. However, these groups have performed their analyses using in-house, large-
sized 3D distortion phantoms that they have developed for MRI. Unfortunately, the commercial 
availability of such large 3D distortion phantoms is currently quite limited, and this study was 
limited to a prototype phantom that was provided by the manufacturer. Despite these limitations, 
it is still informative to use the available equipment to characterize the 3D distortion that could 
be expected near the edges of the field of view. Furthermore, daily acquisition and quantita-
tive analysis of 2D distortion for a large phantom in the transverse, sagittal, and coronal views 
has allowed for routine distortion assessment before daily clinical operation of the MR-SIM.
This supports moving the object of interest toward the MR-SIM isocenter to help mitigate 
this effect, and that distortion will most likely impact regions near the patient periphery. The 
phantom used in this work was ~ 40 × 40 × 40 cm3 and, due to its large size, the integrated 
quadrature coil was used. We expect that these results will be the worst-case scenario. Another 
factor that contributes to geometrical distortion is magnetic field inhomogeneity originating 
from improper gradient offset adjustments or improper magnet shimming. It has been reported 
that open magnet fields have smaller volumes of gradient linearity that can contribute to dimen-
sional errors in images,(19) although this can be combatted by linking multiple patient positions 
together in the magnet’s “sweet spots”.  
Efforts to isolate different components of overall distortion due to system-related distortions 
(i.e., magnetic field distortions and gradient nonlinearity) and patient/object-induced distortions 
(i.e., chemical shifts and susceptibility) are currently underway.(52) Susceptibility effects near 
interfaces, such as the sinuses and tissue, have been quantified by Wang et al.(53) at 3.0T for the 
brain. They revealed that for a 3D-T1 sequence, only 0.1% of the displacements were > 2 mm; 
however, displacements of up to 4 mm were found. Sumanaweera et al.(23) deduced that distor-
tions at the bone/tissue boundary were negligible with respect to image resolution of ~ 1 mm. 
While the dosimetric impact of these distortions has yet to be fully characterized, it can be 
postulated that the largest dosimetric consequences would occur when a lesion was incorrectly 
identified, resulting in a geometric miss. The impact of using vendor provided system-level 
distortion corrections was recently explored at 3.0T and revealed that displacements of up to 
~ 4 mm were observed when vendor corrections were disabled.(54) For a single-fraction SRS 
treatment, six out of 18 displaced lesions studied had > 20% of the target volume outside of the 
90% isodose line. This suggests that proper management of all distortions, particularly in an 
MR-only environment, is imperative. The phantom analysis we performed enabled assessment 
of the overall image quality of the MR-SIM, although  corrections for patient-induced distortions 
cannot be managed by phantom evaluations and will need patient-specific solutions.  
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The approach we are currently evaluating for a 4D MRI motion management solution was 
demonstrated using a programmed motion phantom experiment and a patient case. The under-
estimation of object volume using two-phase 4D MRI acquisitions suggests that the acquisi-
tion of adequate phases (≥ 4) is important. This has also been a limitation described for 4D 
CT, where two-phase internal target volumes (ITVs) underestimated ten-phase ITVs by up to 
12%.(55) The described 4D MRI method builds upon methods previously proposed and validated 
by Hu et al.(47) There are several other groups who have explored 4D MRI solutions, mostly 
simulating 4D CT reconstructions using 2D dynamic MRI acquisitions.(56-58) Ideally, repeti-
tive 3D volume acquisitions would be acquired to reconstruct real-time 4D datasets, although 
it has been reported that frame rates can be quite low, yielding poor signal-to-noise ratio and 
possible interplay between anatomical motion and scan acquisition time.(59) Four-dimensional 
MRI results for a patient with liver cancer provided acceptable image quality and were acquired 
in ~ 7 min. Image contrast was appropriate for delineation of the liver and kidney, although 
further validation against 4D CT is warranted.
It should be noted that scan times are much longer for MR-SIM than CT-SIM, with a single 
MR scan taking 4–7 min compared to < 1 min for a CT scan. Our current MR-SIM patient time 
slots are 1 hr long, with ~ 45 min of active scan time. This long scan time may complicate the 
management of physiological processes, such as bladder and rectal filling, during the MR-SIM 
imaging session. However, gains in acquisition time have been obtained via parallel imag-
ing, or the reconstruction of multichannel k-space data sampled below the Nyquist sampling 
rate.(12,60) The acceleration factor from parallel imaging is related to the number of available coil 
elements, although factors of 2–3 are often used.(61) Compressed sensing has also emerged as 
an attractive option to accelerate acquisition.(60,62) Other readily available methods to improve 
scan efficiency include increasing slice thickness or introducing a slice gap, although at the 
expense of through-plane resolution. 
Implementing a new technology such as MR-SIM in radiation oncology requires a significant 
effort, including a close collaboration with our diagnostic radiology colleagues. Thus far, we 
have developed our QA processes and clinical workflow including immobilization devices and 
imaging sequences to integrate MR-SIM into radiation oncology for prostate, spine, and brain 
cancer cases. In order to consider MR-SIM as a single modality solution for treatment planning, 
several next steps are necessary. First, having MR-SIM software that enables final marking of 
isocenter using MR images will be essential. Patient-induced and system-level distortion cor-
rections must be implemented. We have developed a methodology for generating a synthetic CT 
from MRI data for dose calculation and revealed negligible (< 1%) dose differences between 
the D99%, mean dose, and maximum dose to the clinical target volume of the prostate.(13) 
MR-DRR bounding box analysis yielded < 0.6 mm difference in the anterior–posterior and 
lateral DRRs. In addition, we have performed rigid registration of ~ 400 cone-beam CT (CBCT) 
to CT-SIM and CBCT to MR-SIM with an emphasis on the prostate/rectal interface for a cohort 
of ten prostate cancer patients.(63) Differences in shift positions were < 2 mm different in the 
anterior–posterior direction and < 1 mm in the other two dimensions, thus demonstrating the 
agreement between the two simulation techniques for IGRT purposes. Future work will incor-
porate distortion corrections and extend the work to other treatment sites.  
 
V. CONCLUSIONS
Based on our clinical experience to date, we have integrated MR-SIM into our radiation therapy 
workflow. Through a series of mechanical and image quality characterization tests, we have 
developed our routine quality assurance procedures necessary for further work involving 
MR-guided radiation therapy planning.
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APPENDICES 
Appendix A: Daily Quality Assurance Worksheet
 I. Safety II. Periodic Image Quality Test
 Daily Result  Daily Result
Patient Alarm (Y/N)  Central Frequency (Hz)
RF Coils –   Transmitter Gain (dB)
No Visual Defects (Y/N)
Intercom System (Y/N)  Spatial Resolution
Compressor (Y/N)  Artifact (Y/N)
Helium Upper (%)  Type
Helium Lower (%)  PIQT  Report   (no highlight)Therapist Initials
 
III.  ELPS Accuracy (± 2 mm specification)
  Offset (mm)
Axial 
Sagittal 
Coronal 
IV.  2D Geometric Distortion (Record 2 mm bounding box dimensions in each plane and box dimension.)
 Orientation  Axis  Dimension (mm)
 Transverse Left-Right  Ant-Post
 Sagittal Foot-Head  Ant-Post
 Coronal Foot-Head  Left-Right 
